ATTENTION EDITORS - CAPTION CORRECTION FOR TOR600 TRANSMITTED ON OCTOBER 28, 2013 AT APPROXIMATELY 1450PM GMT. CORRECTING THE LOGO OF MERCK & CO. A CORRECTED VERSION IMMEDIATELY FOLLOWS THIS ADVISORY.... more 
ATTENTION EDITORS - CAPTION CORRECTION FOR TOR600 TRANSMITTED ON OCTOBER 28, 2013 AT APPROXIMATELY 1450PM GMT. CORRECTING THE LOGO OF MERCK & CO. A CORRECTED VERSION IMMEDIATELY FOLLOWS THIS ADVISORY. WE ARE SORRY FOR ANY INCONVENIENCE CAUSED. REUTERS. A branch of drugs and chemicals group Merck is pictured in central German city of Darmstadt in this March 7, 2012, file photo. Merck & Co Inc reported better-than-expected third-quarter earnings, helped by cost cutting, but sales of its Januvia diabetes treatment fell, raising more concerns about growth prospects for the company's biggest product. REUTERS/Alex Domanski/Files (GERMANY - Tags: BUSINESS LOGO HEALTH) TEMPLATE OUT less 
1 / 7
Reuters | Photo By ALEX DOMANSKI / REUTERS
Mon, Oct 28, 2013 11:37 AM EDT